Your browser doesn't support javascript.
loading
Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five-Year International Observational Study.
Poddubnyy, Denis; Sieper, Joachim; Akar, Servet; Muñoz-Fernández, Santiago; Haibel, Hildrun; Diekhoff, Torsten; Protopopov, Mikhail; Altmaier, Elisabeth; Ganz, Fabiana; Inman, Robert D.
Afiliação
  • Poddubnyy D; Charité-Universitätsmedizin Berlin and German Rheumatism Research Center, Berlin, Germany.
  • Sieper J; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Akar S; Izmir Katip Celebi University, Izmir, Turkey.
  • Muñoz-Fernández S; Hospital Universitario Infanta Sofía, Universidad Europea, Madrid, Spain.
  • Haibel H; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Diekhoff T; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Protopopov M; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Altmaier E; GKM Gesellschaft für Therapieforschung mbH, Munich, Germany.
  • Ganz F; AbbVie Inc., Baar, Switzerland.
  • Inman RD; Schroeder Arthritis Institute, University of Toronto, Toronto, Ontario, Canada.
ACR Open Rheumatol ; 6(2): 103-110, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38111125
ABSTRACT

OBJECTIVE:

To evaluate progression from nonradiographic (nr-) to radiographic axial spondyloarthritis (r-axSpA) over 5 years in patients with recently diagnosed (≤1 year) axSpA fulfilling the Assessment of SpondyloArthritis international Society (ASAS) classification criteria.

METHODS:

A prospsective, observational study (Patients with Axial Spondyloarthritis Multi-Country Registry of Clinical Characteristics) was conducted in rheumatology practices in 29 countries. Baseline and follow-up radiographs of sacroiliac joints were centrally evaluated by three readers according to the grading system of the modified New York criteria for patients initially classified as nr-axSpA. Radiographic progression from nr-axSpA to r-axSpA was evaluated by Kaplan-Meier analysis. Cox proportional regression analyses for progression from nr-axSpA to r-axSpA were also conducted.

RESULTS:

Among 2,165 patients with axSpA, 1,612 (74%) were classified as having r-axSpA (1,050 [65%]) or nr-axSpA (562 [35%]) by central reading. Of 246 patients with nr-axSpA (mean [SD] symptom duration 4.4 [6.2] years) who had at least one follow-up sacroiliac joint radiograph, progression from nr-axSpA to r-axSpA at any follow-up visit was observed in 40 patients (16%) over 5 years. Mean time to radiographic progression was 2.4 years (ranging from 0.9 to 5.1 years). Progression to r-axSpA was associated with male sex (hazard ratio [HR] 3.16 [95% CI 1.22-8.17]), fulfillment of the imaging arm of the ASAS classification criteria (HR 6.64 [1.37-32.25]), and good response to nonsteroidal anti-inflammatory drugs (HR 4.66 [1.23-17.71]).

CONCLUSION:

16% of patients with nr-axSpA progressed to r-axSpA within 5 years. Male sex, fulfillment of the imaging arm of the ASAS criteria, and good response to nonsteroidal anti-inflammatory drugs were predictors of radiographic progression in patients with recently diagnosed axSpA.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article